Lung Cancer: Targets and Therapy, Volume 3, Issue (2012)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Lung Cancer: Targets and Therapy, Volume 3, Issue (2012)

See all volumes and issues
Vol 15, 2024 Vol 14, 2023 Vol 13, 2022 Vol 12, 2021 Vol 11, 2020 Vol 10, 2019 Vol 9, 2018 Vol 8, 2017 Vol 7, 2016 Vol 6, 2015 Vol 5, 2014 Vol 4, 2013 Volume 3, 2012 Vol 2, 2011 Vol 1, 2010
Download citations Download PDFs Download issue

Review

Review Article
Single nucleotide polymorphisms as susceptibility, prognostic, and therapeutic markers of nonsmall cell lung cancer
Shanbeh Zienolddiny & Vidar Skaug
Pages: 1-14
Published online: 30 Dec 2011
AbstractforSingle nucleotide polymorphisms as susceptibility, prognostic, and therapeutic markers of nonsmall cell lung cancer | Full Text | References | PDF (322.5 KB)
  • 107 Views
  • 9 CrossRef citations
  • 0Altmetric
Open Access

Original Research

Article
A pilot study of a metronomic chemotherapy regimen with weekly low-dose docetaxel for previously treated non-small cell lung cancer
Takashi Yokoi, Takeshi Tamaki, Toshiki Shimizu & Shosaku Nomura
Pages: 15-20
Published online: 18 May 2012
AbstractforA pilot study of a metronomic chemotherapy regimen with weekly low-dose docetaxel for previously treated non-small cell lung cancer | Full Text | References | PDF (157.5 KB)
  • 56 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Review

Review Article
Update on biomarkers for the detection of lung cancer
Eloisa Jantus-Lewintre, Marta Usó, Elena Sanmartín & Carlos Camps
Pages: 21-29
Published online: 12 Jun 2012
AbstractforUpdate on biomarkers for the detection of lung cancer | Full Text | References | PDF (214.2 KB)
  • 110 Views
  • 7 CrossRef citations
  • 0Altmetric
Open Access
Review Article
Non-small cell lung cancer: the era of targeted therapy
Mara B Antonoff & Jonathan D’Cunha
Pages: 31-41
Published online: 21 Dec 2022
AbstractforNon-small cell lung cancer: the era of targeted therapy | Full Text | References | PDF (381.4 KB)
  • 58 Views
  • 2 CrossRef citations
  • 0Altmetric
Open Access

Original Research

Article
Economic evaluation of pemetrexed versus erlotinib as second-line treatment of patients with advanced/metastatic non-small cell lung cancer in Greece: a cost minimization analysis
VF Fragoulakis, AG Pallis, DK Kaitelidou, NM Maniadakis & VG Georgoulias
Pages: 43-51
Published online: 16 Jul 2012
AbstractforEconomic evaluation of pemetrexed versus erlotinib as second-line treatment of patients with advanced/metastatic non-small cell lung cancer in Greece: a cost minimization analysis | Full Text | References | PDF (261.9 KB)
  • 97 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Review

Review Article
MET targeted therapy for lung cancer: clinical development and future directions
Yan Feng & Patrick C Ma
Pages: 53-67
Published online: 10 Aug 2012
AbstractforMET targeted therapy for lung cancer: clinical development and future directions | Full Text | References | PDF (1.7 MB)
  • 57 Views
  • 1 CrossRef citations
  • 0Altmetric
Open Access

Original Research

Article
Association of p21 Ser31Arg and p53 Arg72Pro polymorphisms with lung cancer risk in CAPUA study
Ana Souto-García, Ana Fernández-Somoano, Teresa Pascual, Sara M Álvarez-Avellón & Adonina Tardón
Pages: 69-78
Published online: 21 Dec 2022
AbstractforAssociation of p21 Ser31Arg and p53 Arg72Pro polymorphisms with lung cancer risk in CAPUA study | Full Text | References | PDF (294.7 KB)
  • 49 Views
  • 2 CrossRef citations
  • 0Altmetric
Open Access

Review

Review Article
Lung cancer in women
Raúl Barrera-Rodriguez & Jorge Morales-Fuentes
Pages: 79-89
Published online: 21 Dec 2022
AbstractforLung cancer in women | Full Text | References | PDF (218.9 KB)
  • 243 Views
  • 17 CrossRef citations
  • 0Altmetric
Open Access
Review Article
Anaplastic lymphoma kinase (ALK) inhibitors for second-line therapy of non-small cell lung cancer
Thierry Berghmans, Myriam Remmelink & Ahmad Awada
Pages: 91-99
Published online: 21 Dec 2022
AbstractforAnaplastic lymphoma kinase (ALK) inhibitors for second-line therapy of non-small cell lung cancer | Full Text | References | PDF (297.5 KB)
  • 45 Views
  • 2 CrossRef citations
  • 0Altmetric
Open Access

Explore articles